McLean Hospital/Harvard Medical School, Belmont, MA, USA.
Assessment. 2022 Dec;29(8):1901-1916. doi: 10.1177/10731911211035833. Epub 2021 Aug 10.
Intraindividual change over time is commonly used to estimate treatment effectiveness. However, patients may not respond similarly to a scale after treatment, rendering pre-post change an unreliable metric. The current objective was to investigate longitudinal measurement invariance of the Patient Health Questionnaire-9 and Generalized Anxiety Disorder Scale-7 among 4,323 patients completing a partial hospital program. We used confirmatory factor analysis to determine (1) factor structure at pretreatment and posttreatment and (2) longitudinal invariance, accounting for dependent observations, using both classical and approximate measurement invariance approaches. Results indicated a two-factor solution for both scales. Longitudinal invariance was not established for either scale, thus, using raw score differences from the Patient Health Questionnaire-9 and Generalized Anxiety Disorder Scale-7 for measuring symptom change over time may be problematic. The most longitudinally consistent items captured somatic as opposed to affective/cognitive symptoms. We discuss the potential use of these measures for diagnostic screening and between-group comparisons and suggest alternative ways to monitor client progress over time. Limitations included a majority White sample and uniqueness of a partial hospital setting.
个体内随时间的变化通常用于估计治疗效果。然而,患者在治疗后可能不会对量表做出相同的反应,从而使前后变化成为不可靠的指标。本研究旨在调查在完成部分住院计划的 4323 名患者中,患者健康问卷-9 和广泛性焦虑症量表-7 的纵向测量不变性。我们使用验证性因素分析来确定:(1)治疗前和治疗后的因子结构;(2)使用经典和近似测量不变性方法,考虑到依赖观察,进行纵向不变性。结果表明,两个量表都有两个因子解。两个量表均未建立纵向不变性,因此,使用患者健康问卷-9 和广泛性焦虑症量表-7 的原始分数差异来衡量随时间的症状变化可能存在问题。最具纵向一致性的项目捕捉到躯体症状而非情感/认知症状。我们讨论了这些测量方法在诊断筛查和组间比较中的潜在用途,并建议了监测客户随时间变化的替代方法。局限性包括大多数为白人样本和部分住院环境的独特性。